Josh Kohn-Lindquist$15.6MFollowers@joryko07/10/2023Bought 100% more CRSPCRISPR Therapeutics at $57.46 0123456789
Josh Kohn-Lindquist$15.6MFollowers@joryko07/10/2023New position in CRSPCRISPR Therapeutics at $57.49 0123456789
Josh Kohn-Lindquist$15.6MFollowers@joryko07/10/2023New position in CRSPCRISPR Therapeutics at $57.46 0123456789
Tyler Caruso$14.4MFollowers@tc2603/02/2023Bought to close all CRSP1.26% GAINCRISPR Therapeutics at $47.39 0123456789
Tyler Caruso$14.4MFollowers@tc2603/01/2023Bought to close 50% CRSP0.47% GAINCRISPR Therapeutics at $47.77 0123456789
Tyler Caruso$14.4MFollowers@tc2602/27/2023Sold short 100% more CRSPCRISPR Therapeutics at $48.01 0123456789
Tyler Caruso$14.4MFollowers@tc2602/24/2023Bought to close all CRSP0.55% GAINCRISPR Therapeutics at $47.62 0123456789
Tyler Caruso$14.4MFollowers@tc2602/24/2023Sold 150% of CRSP-62.63% LOSSCRISPR Therapeutics at $47.89 0123456789